Cytovance® Biologics (www.cytovance.com) was founded to help biopharmaceutical companies move recombinant protein and antibody products rapidly from the bench through clinical development.
Location: United States, Oklahoma, Oklahoma City
Employees: 201-500
Phone: +1 405-319-8310
Total raised: $42.5M
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Great Poin... | gppfunds.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.10.2014 | - | $20M | - |
| 15.03.2011 | - | $22.5M | - |
Mentions in press and media 9
| Date | Title | Description |
| 03.05.2023 | Antibody Reduction in Bioprocessing: Analytical Detection and Steps for Mitigation, Upcoming Webinar Hosted by Xtalks | This webinar will highlight a case study of a new monoclonal antibody undergoing process optimization where antibody reduction was encountered showing partial related substances present at 38 percent by area. TORONTO (PRWEB) May 03, 2023 An... |
| 30.11.2022 | A Strain Development Strategy to Enhance Screening, Process Development and Scale-Up, Upcoming Webinar Hosted by Xtalks | Through this webinar, the speaker wishes to highlight the importance of an efficient strain development strategy in order to reduce the timelines and the costs associated with product development. TORONTO (PRWEB) November 30, 2022 Any curre... |
| 21.11.2022 | Downstream Process Development of a Complicated Fusion Protein, Upcoming Webinar Hosted by Xtalks | The speaker will present data from small-scale solubilization and refold studies, which were employed to discover optimized conditions for parameters such as buffer formulation as well as incubation time and temperature. TORONTO (PRWEB) Nov... |
| 12.07.2022 | Process Characterization & Statistical Modeling — Transforming Data into Knowledge Throughout the Product Lifecycle, Upcoming Webinar Hosted by Xtalks | The speaker will demonstrate the benefits of employing a definitive screening design…which builds high-performance predictive models through auto-validation techniques. TORONTO (PRWEB) July 12, 2022 It’s no surprise that data plays a pivota... |
| 23.08.2021 | Production of Therapeutic Proteins in CHO cells, Integrated Mobile Clinical Services, Upcoming Webinar Hosted by Xtalks | Together, the Cytovance upstream and downstream platform processes meet a key need in the biologic industry to produce high quality product in conjunction with accelerated timelines and reduced costs on the path from cell line to clinical m... |
| 28.04.2021 | Accelerating Biologics Drug Development with an Expanding Analytical Toolkit, Upcoming Webinar Hosted by Xtalks | Powerful analytics can decrease timelines and enhance process robustness, but also provide a deeper understanding of the impact of process steps on product quality. TORONTO, Ontario (PRWEB) April 28, 2021 Development of innovative biologics... |
| 17.02.2021 | Regulatory Strategies for Gene Therapy Product Development, Upcoming Webinar Hosted by Xtalks | This is an exciting time in the industry with products being developed at an accelerated rate. TORONTO (PRWEB) February 17, 2021 The regulatory landscape for gene therapy is constantly changing and global harmonization has yet to be aligned... |
| 28.10.2014 | Cytovance Biologics Receives $20M Senior Credit Facility | Cytovance Biologics, Inc., Oklahoma City, Oklahoma-based contract manufacturing organization of mammalian and microbial biologics, received a $20m senior credit facility. Monroe Capital provided the financing. The company intends to use the... |
| 15.03.2011 | Cytovance Biologics Receives $22.5M in Equity Financing | Cytovance Biologics, an Oklahoma City-based full service contract manufacturer of mammalian and microbial biologics for biotechnology and pharmaceutical companies, has raised $22.5m in equity financing. Investors include Great Point Partner... |